Xlife Sciences AG Cash Flow-to-Debt Ratio
Xlife Sciences AG cash flow-to-debt ratio. Xlife Sciences AG (XLS) has a Cash Flow-to-Debt Ratio of 0.00x as of June 2025, meaning its operating cash flow of CHF-803.62K could theoretically repay 0% of its total liabilities (CHF232.84 Million) in one year. Check earnings quality score of Xlife Sciences AG to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Xlife Sciences AG (2019–2025)
Cash flow-to-debt ratio of Xlife Sciences AG from 2019 to 2025. Historical debt coverage capacity for Xlife Sciences AG across 7 annual periods. Check how aggressively does Xlife Sciences AG reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Xlife Sciences AG Cash Flow-to-Debt Ratio by Year (2019–2025)
Xlife Sciences AG cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Xlife Sciences AG. For the full cash flow conversion analysis, see XLS cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (CHF) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.01x | CHF-903.00K | CHF144.76 Million | ▼ -247.9% |
| 2024 | 0.00x | CHF-421.51K | CHF235.11 Million | ▼ -354.5% |
| 2023 | 0.00x | CHF171.78K | CHF243.82 Million | ▲ +103.9% |
| 2022 | -0.02x | CHF-4.61 Million | CHF255.00 Million | ▼ -12.3% |
| 2021 | -0.02x | CHF-4.32 Million | CHF268.83 Million | ▼ -122.4% |
| 2020 | -0.01x | CHF-401.55K | CHF55.51 Million | ▼ -2.9% |
| 2019 | -0.01x | CHF-398.24K | CHF56.64 Million | — |